Botanix Pharmaceuticals Limited (AU:BOT) has released an update.
Botanix Pharmaceuticals Limited invites shareholders to its Commercial Day Webinar on September 17, 2024, for an update on the commercial launch of Sofdra™, their FDA-approved treatment for primary axillary hyperhidrosis. The webinar, hosted by Executive Chairman Vince Ippolito and CEO Dr. Howie McKibbon, will feature insights from industry experts and key commercial team members. Registration for the event is now open, with details available upon sign-up.
For further insights into AU:BOT stock, check out TipRanks’ Stock Analysis page.